{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:16:25Z","timestamp":1769850985112,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.anai.2017.12.004","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T22:24:21Z","timestamp":1520288661000},"page":"285-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Phenotyping patients with chronic cough: Evaluating the ability to predict the response to anti-inflammatory therapy"],"prefix":"10.1016","volume":"120","author":[{"given":"Mahboobeh Haji","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline E.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyn","family":"Morice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2017.12.004_bib0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0015","first-page":"L130","article-title":"Emerging molecular phenotypes of asthma","volume":"308","author":"Ray","year":"2015","journal-title":"Am J Physiol"},{"key":"10.1016\/j.anai.2017.12.004_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pupt.2006.02.001","article-title":"A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma","volume":"20","author":"Boot","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.anai.2017.12.004_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/thorax.58.1.14","article-title":"Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma?","volume":"58","author":"Fujimura","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.anai.2017.12.004_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/2049-6958-5-2-99","article-title":"Cough variant asthma and atopic cough","volume":"5","author":"Magni","year":"2010","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00408-010-9272-1","article-title":"Cough hypersensitivity syndrome: a distinct clinical entity","volume":"189","author":"Morice","year":"2011","journal-title":"Lung"},{"key":"10.1016\/j.anai.2017.12.004_bib0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2169\/internalmedicine.31.447","article-title":"Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness","volume":"31","author":"Fujimura","year":"1992","journal-title":"Intern Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0045","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(89)92801-8","article-title":"Chronic cough: eosinophilic bronchitis without asthma","volume":"1","author":"Gibson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2017.12.004_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1874306401711010017","article-title":"The emerging role of the eosinophil and its measurement in chronic cough","volume":"11","author":"Sadeghi","year":"2017","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.anai.2017.12.004_bib0055","doi-asserted-by":"crossref","first-page":"116s","DOI":"10.1378\/chest.129.1_suppl.116S","article-title":"Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Brightling","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.anai.2017.12.004_bib0060","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.129.1_suppl.1S","article-title":"Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Irwin","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.anai.2017.12.004_bib0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1081\/JAS-120002285","article-title":"Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma","volume":"39","author":"Dicpinigaitis","year":"2002","journal-title":"J Asthma"},{"key":"10.1016\/j.anai.2017.12.004_bib0070","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1164\/ajrccm.159.6.9809047","article-title":"Exhaled nitric oxide as a noninvasive assessment of chronic cough","volume":"159","author":"Chatkin","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0075","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1378\/chest.07-2541","article-title":"Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough","volume":"134","author":"Oh","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.anai.2017.12.004_bib0080","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","author":"American Thoracic Society; European Respiratory Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0085","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2017.12.004_bib0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1745-9974-2-8","article-title":"The automatic recognition and counting of cough","volume":"2","author":"Barry","year":"2006","journal-title":"Cough"},{"key":"10.1016\/j.anai.2017.12.004_bib0100","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1183\/09031936.00057407","article-title":"The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough","volume":"31","author":"Birring","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2017.12.004_bib0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1440-1843.2010.01893.x","article-title":"Quantifying chronic cough: objective versus subjective measurements","volume":"16","author":"Faruqi","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.anai.2017.12.004_bib0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.anai.2017.12.004_bib0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1843.2008.01273.x","article-title":"Exhaled nitric oxide levels in patients with atopic cough and cough variant asthma","volume":"13","author":"Fujimura","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.anai.2017.12.004_bib0120","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.rmed.2015.05.016","article-title":"Extended analysis of exhaled and nasal nitric oxide for the evaluation of chronic cough","volume":"109","author":"Maniscalco","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0125","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.chest.2016.01.006","article-title":"Validity of fractional exhaled nitric oxide in diagnosis of corticosteroid-responsive cough","volume":"149","author":"Yi","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.anai.2017.12.004_bib0130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/02770903.2012.713428","article-title":"Is a single blood eosinophil count a reliable marker for \u201ceosinophilic asthma?\u201d","volume":"49","author":"Spector","year":"2012","journal-title":"J Asthma"},{"key":"10.1016\/j.anai.2017.12.004_bib0135","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01162-2017","article-title":"Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD","volume":"50","author":"Casanova","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2017.12.004_bib0140","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02165-2017","article-title":"Peripheral eosinophil count as a biomarker for the management of COPD: not there yet","volume":"50","author":"Rabe","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2017.12.004_bib0145","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02177-2017","article-title":"Eosinophils in COPD: how many swallows make a summer?","volume":"51","author":"Hamad","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2017.12.004_bib0150","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/S0091-6749(02)81864-4","article-title":"Reduction of eosinophil counts by montelukast in double-blind, randomized, placebo-controlled studies of seasonal allergic rhinitis","volume":"109","author":"Ritter","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2017.12.004_bib0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-9974-10-2","article-title":"A real-life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough","volume":"10","author":"Mincheva","year":"2014","journal-title":"Cough"},{"key":"10.1016\/j.anai.2017.12.004_bib0160","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1081\/JAS-200027851","article-title":"Treatment of chronic cough in children with montelukast,a leukotriene receptor antagonist","volume":"41","author":"Kopriva","year":"2004","journal-title":"J Asthma"},{"key":"10.1016\/j.anai.2017.12.004_bib0165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2222.2004.01978.x","article-title":"Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children","volume":"34","author":"Gagro","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2017.12.004_bib0170","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0016-5085(89)90627-6","article-title":"Mast cells are closely apposed to nerves in the human gastrointestinal mucosa","volume":"97","author":"Stead","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anai.2017.12.004_bib0175","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1164\/ajrccm\/143.3_Pt_2.S55","article-title":"Mast cell\/nerve interactions in vitro and in vivo","volume":"143","author":"Bienenstock","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.anai.2017.12.004_bib0180","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","article-title":"P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study","volume":"385","author":"Abdulqawi","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2017.12.004_bib0185","first-page":"A2672","article-title":"The neurokinin-1 receptor antagonist orvepitant is a novel anti-tussive therapy for chronic refractory cough: results from a phase 2 Study (VOLCANO-1)","volume":"195","author":"Allman","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0190","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/bjp.2008.196","article-title":"Leukotriene D4 increases the excitability of capsaicin-sensitive nasal sensory nerves to electrical and chemical stimuli","volume":"154","author":"Taylor-Clark","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.anai.2017.12.004_bib0195","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.rmed.2009.01.019","article-title":"Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial","volume":"103","author":"Ramsay","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2017.12.004_bib0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/02770900801888863","article-title":"The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma","volume":"45","author":"Kawai","year":"2008","journal-title":"J Asthma"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120617313777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120617313777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:19:02Z","timestamp":1761052742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120617313777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1081120617313777"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2017.12.004","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotyping patients with chronic cough: Evaluating the ability to predict the response to anti-inflammatory therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2017.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017. Published by Elsevier Inc. on behalf of the American College of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}